Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Viracta Therapeutics Inc (VIRX)

Viracta Therapeutics Inc (VIRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0250 unch (unch) 03/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0250 unch (unch) 15:54 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0229
Day High
0.0250
Open 0.0246
Previous Close 0.0250 0.0250
Volume 105,600 105,600
Avg Vol 245,630 245,630
Stochastic %K 11.00% 11.00%
Weighted Alpha -84.63 -84.63
5-Day Change -0.0010 (-3.85%) -0.0010 (-3.85%)
52-Week Range 0.0080 - 1.3100 0.0080 - 1.3100
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 994
  • Shares Outstanding, K 39,744
  • Annual Sales, $ 0 K
  • Annual Income, $ -51,060 K
  • EBIT $ -47 M
  • EBITDA $ -49 M
  • 60-Month Beta 1.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.10
  • Most Recent Earnings $-0.27 on 11/13/24
  • Next Earnings Date 03/27/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 455.12%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +285,528.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0200 +25.00%
on 03/12/25
Period Open: 0.0370
0.0700 -64.29%
on 03/07/25
-0.0120 (-32.43%)
since 02/21/25
3-Month
0.0080 +212.50%
on 02/11/25
Period Open: 0.2100
0.2554 -90.21%
on 12/26/24
-0.1850 (-88.10%)
since 12/20/24
52-Week
0.0080 +212.50%
on 02/11/25
Period Open: 1.0700
1.3100 -98.09%
on 04/12/24
-1.0450 (-97.66%)
since 03/21/24

Most Recent Stories

More News
Viracta Therapeutics Announces Wind Down of Operations

VIRX : 0.0250 (unch)
Stocks Set to Open Lower as Investors Trim Risk Amid Year-End Uncertainty

March S&P 500 E-Mini futures (ESH25) are down -0.22%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.20% this morning, adding to Friday’s declines on Wall Street, as market participants reduced...

NFLX : 960.29 (+0.99%)
JWN : 24.35 (+0.16%)
NVDA : 117.70 (-0.70%)
LW : 53.08 (+0.63%)
AAL : 11.39 (+1.15%)
ARTV : 4.27 (+5.69%)
ESH25 : 5,617.80s (-0.79%)
BYW6.D.DX : 8.180 (-6.19%)
VIRX : 0.0250 (unch)
TSLA : 248.71 (+5.27%)
NQH25 : 19,450.81s (-1.16%)
RCKT : 8.43 (+1.32%)
Stock Index Futures Slip on Pressure from Rising Bond Yields

March S&P 500 E-Mini futures (ESH25) are down -0.36%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.40% this morning, following Thursday’s muted session on Wall Street, as rising Treasury yields...

TGT : 104.06 (-0.13%)
MSTR : 304.00 (+0.64%)
MARA : 12.38 (-0.96%)
DLTR : 66.75 (+3.34%)
ABAT : 1.0300 (-0.96%)
CRKN : 3.5100 (-10.23%)
ESH25 : 5,617.80s (-0.79%)
UNH : 516.85 (+1.09%)
VIRX : 0.0250 (unch)
NQH25 : 19,450.81s (-1.16%)
BTBT : 2.33 (-2.92%)
GME : 24.75 (+5.27%)
Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

VIRX : 0.0250 (unch)
Sunesis: Q3 Earnings Snapshot

Sunesis: Q3 Earnings Snapshot

VIRX : 0.0250 (unch)
Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

VIRX : 0.0250 (unch)
Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

VIRX : 0.0250 (unch)
Sunesis: Q2 Earnings Snapshot

Sunesis: Q2 Earnings Snapshot

VIRX : 0.0250 (unch)
Viracta Therapeutics Announces Chief Executive Officer Leadership Succession to Drive the Next Phase of the Company's Strategic Development and Growth

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the succession...

VIRX : 0.0250 (unch)
Viracta Therapeutics Chief Scientific Officer, Dr. Ayman Elguindy, Elected to the Governing Board of the International Association for Research on Epstein-Barr Virus and Associated Diseases

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the...

VIRX : 0.0250 (unch)

Business Summary

Viracta Therapeutics Inc. is a precision oncology company targeting virus-associated malignancies. The company is pursuing application of inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma and other virus-related cancers. Viracta...

See More

Key Turning Points

3rd Resistance Point 0.0278
2nd Resistance Point 0.0264
1st Resistance Point 0.0257
Last Price 0.0250
1st Support Level 0.0236
2nd Support Level 0.0222
3rd Support Level 0.0215

See More

52-Week High 1.3100
Fibonacci 61.8% 0.8126
Fibonacci 50% 0.6590
Fibonacci 38.2% 0.5054
Last Price 0.0250
52-Week Low 0.0080

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals